相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
A. L. Thompson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management (vol 9, 20155, 2019)
David Andre Barriere et al.
SCIENTIFIC REPORTS (2020)
JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice
Silvia Marino et al.
CALCIFIED TISSUE INTERNATIONAL (2020)
Cannabis Normalization Among Young Adults in a Nigerian City
Emeka W. Dumbili
JOURNAL OF DRUG ISSUES (2020)
Cannabis use among US adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates
Christopher J. Hammond et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2020)
Cannabis as entheogen: survey and interview data on the spiritual use of cannabis
Petter Grahl Johnstad
JOURNAL OF CANNABIS RESEARCH (2020)
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
Francesca Rossi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
Silvia Marino et al.
EBIOMEDICINE (2019)
Cannabinoid Receptor 2 Agonist JWH-015 Inhibits Interleukin-1β-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts and in Adjuvant Induced Arthritis Rat via Glucocorticoid Receptor
Sabrina Fechtner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inhibiting effect of microRNA-187-3p on osteogenic differentiation of osteoblast precursor cells by suppressing cannabinoid receptor type 2
Aihua Xu et al.
DIFFERENTIATION (2019)
Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor
Michal Eger et al.
SCIENTIFIC REPORTS (2019)
The endocannabinoid system: Novel targets for treating cancer induced bone pain
Jia Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Medical Cannabis in the Skilled Nursing Facility: A Novel Approach to Improving Symptom Management and Quality of Life
Zachary J. Palace et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies
Carlijn R. Hooijmans et al.
PLOS ONE (2018)
Bortezomib and endocannabinoid/endovanilloid system: a synergism in osteosarcoma
Francesca Punzo et al.
PHARMACOLOGICAL RESEARCH (2018)
The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism
Axel Klein et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2018)
Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury
Dehao Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor
Silvia Marino et al.
PHARMACOLOGICAL RESEARCH (2017)
Cannabis use and bone mineral density: NHANES 2007-2010
Donald Bourne et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Cannabinoids and autoimmune diseases: A systematic review
Valeria Katchan et al.
AUTOIMMUNITY REVIEWS (2016)
Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease
M. Carnovali et al.
PHARMACOLOGICAL RESEARCH (2016)
β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro
Masayoshi Yamaguchi et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
The role of osteoblasts in bone metastasis
Penelope D. Ottewell
JOURNAL OF BONE ONCOLOGY (2016)
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis
Antonia Sophocleous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
Natalya M. Kogan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Osseous Characteristics of Mice Lacking Cannabinoid Receptor 2 after Pulp Exposure
Elizabeth P. Nikolaeva et al.
JOURNAL OF ENDODONTICS (2015)
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice
A. Sophocleous et al.
OSTEOARTHRITIS AND CARTILAGE (2015)
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency
Reem Smoum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
Marie Smith et al.
PLOS ONE (2015)
SYRCLE's risk of bias tool for animal studies
Carlijn R. Hooijmans et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Disease Modification of Breast Cancer-Induced Bone Remodeling by Cannabinoid 2 Receptor Agonists
Alysia N. Lozano-Ondoua et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonists and Osteoclast Inhibitors: Discovery, Optimization, and Biological Evaluation
Peng Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
Francesca Rossi et al.
BONE (2011)
Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities
Pedro Cunha et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2011)
Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist
Dechun Geng et al.
BIOMATERIALS (2010)
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss
Alysia N. Lozano-Ondoua et al.
LIFE SCIENCES (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese
Qing-Yang Huang et al.
BONE (2009)
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
F. Rossi et al.
BONE (2009)
A critical review of the cannabinoid receptor as a drug target for obesity management
F. Akbas et al.
OBESITY REVIEWS (2009)
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
Joseph Tam et al.
FASEB JOURNAL (2008)
Endocannabinoids and the regulation of bone metabolism
I. Bab et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells
Kerri L. George et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
AI Idris et al.
NATURE MEDICINE (2005)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
分享论文
